Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Harvard Business School
Daiichi Sankyo
Teva
Cantor Fitzgerald
Cerilliant
Colorcon
Medtronic
Julphar

Generated: April 27, 2018

DrugPatentWatch Database Preview

TROVAN Drug Profile

« Back to Dashboard

Which patents cover Trovan, and what generic alternatives are available?

Trovan is a drug marketed by Pfizer and is included in three NDAs.

The generic ingredient in TROVAN is azithromycin dihydrate; trovafloxacin mesylate. There are thirty-two drug master file entries for this compound. Additional details are available on the azithromycin dihydrate; trovafloxacin mesylate profile page.
Drug patent expirations by year for TROVAN
Synonyms for TROVAN
(1|A,5|A,6|A)-7-(6-Amino-3-azabicyclo[3.1.0]hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid methanesulfonate
(1alpha,5alpha,6alpha)-7-(6-Amino-3-azabicyclo[3.1.0]hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid methanesulfonate
(1R,5S,6s)-3-[6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5-oxo-5,8-dihydro-1,8-naphthyridin-2-yl]-3-azabicyclo[3.1.0]hexan-6-aminium methanesulfonate
0P1LKO80WN
1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-(6-amino-3-azabicyclo(3.1.0)hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-, (1alpha,5alpha,6alpha)-, monomethanesulfonate
1,8-Naphthyridine-3-carboxylic acid, 7-(6-amino-3-azabicyclo(3.1.0)hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-(1alpha,5alpha,6alpha)-, monomethanesulfonate
147059-75-4
7-((1R,5S,6s)-6-Amino-3-azabicyclo(3.1.0)hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, monomethanesulfonate
7-[ -6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1- -6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylicacid
7-[(1?,5?,6?)-6-Amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid mesylate
7-[(1|A,5|A,6|A)-6-Amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic Acid Methanesulfonate
7-[(1R,5S,6s)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid methanesulfonate
7-[(1r,5s)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid methanesulfonate(1:1)
7-[(1S,5R)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid; methanesulfonic acid
AC1L1Y47
AC1Q6WCM
AKOS000280396
AKOS015914051
API0008271
C20H15F3N4O3.CH4O3S
CAS-147059-75-4
CCG-221411
CHEBI:77568
CHEMBL1200779
CP 99219
CP 99219-27
CP-99,219-27
CP-99219-27
CP-9921927
D02123
DSSTox_CID_25701
DSSTox_GSID_45701
DSSTox_RID_81073
DTXSID0045701
DYNZICQDCVYXFW-AHZSKCOESA-N
DYNZICQDCVYXFW-GIPYJWDTSA-N
FT-0675705
HE070780
HE312416
HMS3260E16
I14-44539
J-008308
J-690188
LS-95905
METHANESULFONIC ACID; TROVAFLOXACIN
MFCD00913361
MolPort-005-935-608
NCGC00064532-02
NCGC00260792-01
NCGC00263538-01
SCHEMBL40874
SCHEMBL40875
Tox21_110980
Tox21_110980_1
Tox21_500107
Trovafloxacin mesilate
Trovafloxacin mesylate
Trovafloxacin mesylate (USAN)
Trovafloxacin mesylate [USAN]
Trovafloxacin mesylate, >98% (HPLC)
Trovafloxacin methanesulfonate
trovafloxacin monomesylate
Trovafloxacin monomethanesulfonate
Trovafloxacin sulfate
Trovan (TN)
Turvel
UNII-0P1LKO80WN
X2013

US Patents and Regulatory Information for TROVAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-001 Dec 18, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer TROVAN PRESERVATIVE FREE alatrofloxacin mesylate INJECTABLE;INJECTION 020760-002 Dec 18, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer TROVAN PRESERVATIVE FREE alatrofloxacin mesylate INJECTABLE;INJECTION 020760-001 Dec 18, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for TROVAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-001 Dec 18, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-001 Dec 18, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Army
Harvard Business School
Farmers Insurance
Daiichi Sankyo
Queensland Health
Mallinckrodt
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.